Medical Application of the SARAF-Proton/Deuteron 40 MeV Superconducting Linac

Journal Article · Mon Nov 26 00:00:00 EST 2007 · AIP Conference Proceedings

DOI:https://doi.org/10.1063/1.2825799· OSTI ID:21039404

Halfon, Shlomi ^[1]

---

1. Soreq NRC, Yavne, 81800 Israel and Racah Institute of Physics, Hebrew University, Jerusalem, 91904 (Israel)

The Soreq Applied Research Accelerator Facility (SARAF) is based on a superconducting linear accelerator currently being built at the Soreq research center (Israel). The SARAF is planned to generate a 2 mA 4 MeV proton beam during its first year of operation and up to 40 MeV proton or deuteron beam in 2012. The high intensity beam, together with the linac ability to adjust the ion energy provides opportunities for medical research, such as Boron Neutron Capture Therapy (BNCT) and the production of medical radioisotopes, for instance {sup 103}Pd for prostate brachytherapy.

• OSTI ID: 21039404
• Journal Information: AIP Conference Proceedings, Vol. 958, Issue 1; Conference: 4. International summer school on nuclear physics methods and accelerators in biology and medicine, Prague (Czech Republic), 8-19 Jul 2007; Other Information: DOI: 10.1063/1.2825799; (c) 2007 American Institute of Physics; Country of input: International Atomic Energy Agency (IAEA); ISSN 0094-243X
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
ACCELERATOR FACILITIES
BORON
BRACHYTHERAPY
CAPTURE
DEUTERON BEAMS
DEUTERONS
LINEAR ACCELERATORS
MEV RANGE
NEUTRON CAPTURE THERAPY
NEUTRONS
PALLADIUM 103
PROSTATE
PROTON BEAMS
PROTONS